Related Experiment Videos
Update on assessment activities. United States perspective
International Journal of Technology Assessment in Health Care
|December 11, 1987
Summary
This paper updates biomedical technology assessment in the US, focusing on the National Institutes of Health (NIH) Consensus Development Program (CDP). It examines recent changes, impacts, and challenges in healthcare technology evaluation.
Area of Science:
- Biomedical Technology Assessment
- Health Services Research
- Health Policy
Background:
- Previous work detailed the National Institutes of Health (NIH) Consensus Development Program (CDP) in 1985.
- The 1985 work also covered the transfer of consensus-enhanced scientific information and its impact on US medical practice.
Purpose of the Study:
- To provide an updated overview of biomedical technology assessment activities in the United States.
- To analyze changes in the environment for US technology assessment efforts over the past year.
- To address the specific technology assessment and transfer activities undertaken by the NIH.
Main Methods:
- Review of recent developments in US technology assessment.
- Analysis of the broader framework influencing technology assessment.
- Examination of specific NIH technology assessment and transfer initiatives.
Main Results:
- Identified shifts in the climate surrounding US technology assessment.
- Assessed the consequences of these environmental changes.
- Highlighted emerging challenges for quality healthcare provision.
Conclusions:
- Technology assessment in the US operates within a dynamic and evolving framework.
- The NIH plays a significant role in technology assessment and information transfer.
- Adapting to changes is crucial for ensuring quality healthcare through effective technology evaluation.